Skip to main content

Govt talking to Russia for possible Advancement of its Covid-19 Vaccine here: Health Ministry

By Unknown

The Centre is in consultations with the Russian government for exploring the possibility of cooperation between the two countries for advancing the Covid-19 vaccine in India, Parliament was told on Friday.

The Central Drugs Standard Control Organisation (CDSCO) has informed that it has received information about one Covid-19 vaccine developed and approved in Russia,  Minister of State for Health Ashwini Choubey informed the Lok Sabha.   

Further, the Indian Council of Medical Research (ICMR), an autonomous organisation under the Department of Health Research, has informed that as per information available from WHO draft landscape of Covid-19 vaccine (last updated on September 17), globally there are 36 candidate vaccines which are under various stages of clinical trials. 

"Of this only 02 are Indian candidates (Bharat Biotech International Ltd. and Cadila Healthcare). All 36 candidates are under various stages of clinical trials. None of the candidate vaccines so far has completed all stages of a clinical trial," he said in a written reply.

In response to a question on whether the government is in talks with Russia and other countries to procure Covid-19 vaccine doses in the upcoming months, Choubey said, "The Department of Biotechnology has informed that the Government of India is in consultations with the Russian Government for exploring the possibility of cooperation with Russia for advancing Covid-19 Vaccine in India."

Further, Phase II and III bridging studies of ChAdOx1-S, a vaccine developed by University of Oxford/AstraZeneca have been initiated in India.

"While the government and industry are trying their best to make available a safe and effective vaccine for Covid-19 at the earliest, it is difficult to comment on the exact timelines in view of various complex pathways involved in vaccine development," the minister underlined.

Elaborating on the steps taken by the government for timely availability of Covid-19 drugs and vaccination, Choubey informed that CDSCO has approved the manufacturing and marketing of three drugs --- Remdesivir Injectable formulations, Favipiravir tablets, Itolizumab injection -- for restricted emergency use in the country for treatment of coronavirus infection.

Further, the CDSCO has granted permission for conduct of phase I and II clinical trials of the two vaccine candidates indigenously developed by Bharat Biotech in collaboration with ICMR and Cadila Healthcare Ltd.

Besides, it has also given permission to the Serum Institute of India to conduct phase II and III clinical trial of the Oxford Covid-19 vaccine, the minister said.


Comments

Post a Comment

Popular posts from this blog

Iran, Russia Discussing Joint Production Of COVID-19 Vaccine

By Unknown
Iran and Russia's sovereign wealth fund RDIF are discussing the joint production of a vaccine against COVID-19, Russian news agencies cited the Iranian ambassador to Moscow as saying on Friday. "We are holding talks, I spoke with the head of RDIF Kirill Dmitriev, our officials have held several rounds of consultations and we announced that we will co-operate," Ambassador to Moscow Kazem Jalali was cited as saying. Thus far, Russia has struck a manufacturing partnership deal with India, which is due to produce 300 million doses of the 'Sputnik-V' vaccine domestically. It is also discussing such partnerships with several other countries, including Brazil.
Post a Comment
Read more

Increased risks of drop out for women and girls : CoronaVirus Updates

By Unknown
The total number of children not returning to their education after the school closures is likely to be significant. The pandemic also risks jeopardizing some of the gains made since 2001 in re-building women and girls’ education following the Taliban regime.  The COVID-19 pandemic is creating additional barriers due to risks—and students’ and parents’ anxiety about risks—associated with children returning to classrooms that are cramped, with no capacity for distancing, often cold, damp and poorly ventilated during the country’s severe winters, and have no or poor hygiene and clean water facilities. The COVID-19 pandemic is likely to drive many women and girls out of education permanently. School closures due to COVID-19, resulting increases in caregiving responsibilities for women and girls, and increases in poverty and unemployment will all make it harder for women and girls to study.  These factors combine in harmful ways with pre-existing discriminatory gender norms, o...
Post a Comment
Read more

Russia's Covid-19 vaccine Sputnik V available to public now: State media

By Unknown
First batches of Russia's Covid vaccine Sputnik V have entered "civil circulation" in capital Moscow, state media reported on Thursday. While details on the process were not immediately available, Russia has repeatedly stressed on producing the vaccine at the earliest, a belief met with international scepticism. Earlier this month, the Russian health ministry had said that batches of the Covid-19 vaccine were being produced for public distribution and would be supplied to different regions soon. "The first batch of the vaccine for preventing the novel coronavirus infection, Gam-COVID-Vac (Sputnik V) developed by the Gamaleya Research Institute of Epidemiology and Microbiology of the Russian Health Ministry passed the required quality tests in the laboratories of Roszdravnadzor (the Federal Service for Surveillance in Healthcare) and was produced for civilian circulation. In the near future the supplies of the first batches of the vaccine to the regions are expected...
Post a Comment
Read more